Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory.


Journal

Current drug safety
ISSN: 2212-3911
Titre abrégé: Curr Drug Saf
Pays: United Arab Emirates
ID NLM: 101270895

Informations de publication

Date de publication:
2019
Historique:
received: 11 06 2018
revised: 23 08 2018
accepted: 27 08 2018
pubmed: 30 8 2018
medline: 11 5 2019
entrez: 30 8 2018
Statut: ppublish

Résumé

To report a case of a 73-year-old man who presented with decreased visual acuity due to bilateral macular edema after paclitaxel administration for prostate cancer. The ophthalmic evaluation consisted of medical and ocular history, Best Corrected Visual Acuity, slit-lamp biomicroscopy and Spectral-domain optical coherence tomography / Fluorescein Angiography. Optical Coherence Tomography and Fluorescein Angiography revealed silent cystoid macular edema. After consulting with the oncologist, the cessation of paclitaxel therapy was decided. The patient presented a gradual but steady resumption of the retinal edema, with complete restoration of normal retinal morphology and function within two months. The pathogenesis of the silent Cystoid Macular Edema (CME) is still unclear. Based on our case and a critical review of the previous observations and published data, we propose that the underlying cause of Taxane induced CME is the functional failure of Aquaporin mediated water transport at the level of retinal Intermediate and Deep capillary plexuses, and at lesser extent at the level of the Retinal Pigment Epithelium. Taxane induced silent CME should be attributed to the action of Taxanes on the microtubule guided aquaporin vesicles transport to the cell membrane. In our case of Taxane induced silent CME, withdrawal of the taxane was enough for complete recovery, and no additional treatment was needed.

Identifiants

pubmed: 30156164
pii: CDS-EPUB-92650
doi: 10.2174/1574886313666180828163016
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Bridged-Ring Compounds 0
Taxoids 0
taxane 1605-68-1
Paclitaxel P88XT4IS4D

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-47

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

M Kanakis (M)

University of Patras, Medical School, University Eye Clinic, Rion University Hospital, Patras, Greece.

I Georgalas (I)

University of Athens, Medical School, 1st University Eye Clinic, G. Genimatas General Hospital, Athens, Greece.

T Makatsoris (T)

Department of Medicine, Division of Oncology, University of Patras, Medical School, Rion University Hospital, Patras, Greece.

N Pharmakakis (N)

University of Patras, Medical School, University Eye Clinic, Rion University Hospital, Patras, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH